½ðʨ¹ó±ö»á3420055

½ðʨ¹ó±ö»á-±öÖÁÈç¹é-×ð¹ó-ÏÔºÕ ½ðʨ¹ó±ö»á-±öÖÁÈç¹é-×ð¹ó-ÏÔºÕ

²úÆ·ÖÐÐÄ

½ðʨ¹ó±ö»á-±öÖÁÈç¹é-×ð¹ó-ÏÔºÕ
È˶ËÁ£³¤¶È¶¨Á¿qPCR¼ì²âÊÔ¼ÁºÐ
EQ022
½ðʨ¹ó±ö»á-±öÖÁÈç¹é-×ð¹ó-ÏÔºÕ¹æ¸ñ£º ½ðʨ¹ó±ö»á-±öÖÁÈç¹é-×ð¹ó-ÏÔºÕ¼ÛÇ®£º
100rxn £¤2030.00
500rxn £¤6090.00

Overview ÎÄÏ×

Product name: Human Telomere Length Quantification qPCR Assay Kit
²úÆ·ÏÈÈÝ: ¶ËÁ££¨Telomere£©ÊÇÓɶà¸öÖظ´ºËÜÕËáÔª¼þ(TTAGGG)Ëù´®Áª×é³ÉµÄÒ»¶ÎÕæºËϸ°ûȾɫÌå×îºóµÄDNAÐòÁУ¬³ýÁËÌṩ·Çת¼DNAµÄ»º³åÎïÍ⣬»¹Äܱ£»¤È¾É«Ìå×îºóÃâÓÚÈںϺÍÍË»¯£¬±£»¤È¾É«Ìå½á¹¹Îȹ̺ÍÒÅ´«ÍêÕû¡£¶ËÁ£ÊÇһСÎÒ˽¼ÒÀÏ»¯ËÙÂʵÄ×îÖ÷ÒªºÍ׼ȷµÄÖ¸±ê£¬ËüµÄ³õʼ³¤¶ÈÓÉÒÅ´«ºÍÇéÐÎÒòËؾöÒ飬²¢ÇÒ»áËæ×Åʱ¼äµÄÍÆÒƶøïÔÌ­¡£ÓÐÑо¿Åú×¢£¬¶ËÁ£³¤¶ÈÓëDNAÐÞ¸´¡¢ÐàÂõ¡¢Ï¸°ûµòÍö¼°Ö×Áö±¬·¢µÈÓÐÇ×½üµÄÁªÏµ£¬Òò´Ë£¬¹ØÓÚÑо¿Ö°Ô±À´Ëµ£¬×¼È·¶ø¿ÉÖظ´µØÕÉÁ¿¶ËÁ£³¤¶ÈÓÈΪÖ÷Òª¡£ ±¾²úÆ·Ö÷Òª½ÓÄÉÏà¶Ô¶¨Á¿qPCRÀ´Ö±½Ó½ÏÁ¿Ñù±¾µÄƽ¾ù¶ËÁ£³¤¶È£¬¼´½ÓÄɶËÁ£Öظ´ÐòÁУ¨Tel£©µÄ¿½±´ÊýÓë»ùÒò×éµ¥¿½±´»ùÒò£¨SCR£©µÄ¿½±´Êý±ÈÖµ(T/S)×÷Ϊ¶ËÁ£Ïà¶Ô³¤¶È¡£µ¥¿½±´»ùÒòÒýÎï(SCR)ÌØÒìÐÔʶ±ð²¢À©ÔöÈËÀà11ºÅȾɫÌåÉÏ78bp³¤µÄÇøÓò¡£ ÊÔ¼ÁºÐÖеÄÒýÎï×éÒÑͨ¹ýÄ¥Á·£¬¿ÉÈ·±££º£¨1£©¸ßЧ¿É¿¿µÄ¶¨Á¿£»£¨2£©ÎÞ·ÇÌØÒìÐÔÀ©Ôö¡£Ã¿×éÒýÎï¾ùÒѾ­ÓÉÀ©ÔöÇúÏßЧÂÊÑéÖ¤£¨E>98%£¬R2>0.99£©£¬ÈÜ»¯ÇúÏßÆÊÎöÒÔ¼°Äý½ºµçÓ¾ÑéÖ¤¡£
²úÆ·Ìصã: ¿ìËÙ»ñµÃЧ¹û£¬¿É½ÚÔ¼¶à´ï 50%µÄʱ¼ä
ÓÅ»¯µÄ¼´ÓÃÐÍÔ¤»ìÒºÓÃÓÚ¿ìËÙ PCR ·´Ó¦
׼ȷ¼ì²âÖÖÖÖÆðʼÁ¿µÄÄ£°å£¬À©ÔöÎȹ̡¢¶¨Á¿Ð§¹û¾ßÓи߶ÈÖظ´ÐÔ
ƽºâµÄ K+ ºÍ NH+ Àë×ÓÅä±È£¬ ÒÔ¼°×ÔÁ¦µÄ ROX Reference Dye °ü×°£¬ ÊÊÓÃËùÓÐreal-time PCR ÒÇÆ÷
  • Scientific Reports

    Effect of obesity and NAFLD on leukocyte telomere length and hTERT gene MNS16A VNTR variant

    ½ðʨ¹ó±ö»á-±öÖÁÈç¹é-×ð¹ó-ÏÔºÕÈÕÆÚ£º2024-10-23 ½ðʨ¹ó±ö»á-±öÖÁÈç¹é-×ð¹ó-ÏÔºÕIF£º3.8
  • Scientific Reports

    Effect of obesity and NAFLD on leukocyte telomere length and hTERT gene MNS16A VNTR variant

    ½ðʨ¹ó±ö»á-±öÖÁÈç¹é-×ð¹ó-ÏÔºÕÈÕÆÚ£º2024-12-09 ½ðʨ¹ó±ö»á-±öÖÁÈç¹é-×ð¹ó-ÏÔºÕIF£º3.8
  • Scientific Reports

    Effect of obesity and NAFLD on leukocyte telomere length and hTERT gene MNS16A VNTR variant

    ½ðʨ¹ó±ö»á-±öÖÁÈç¹é-×ð¹ó-ÏÔºÕÈÕÆÚ£º2024-12-09 ½ðʨ¹ó±ö»á-±öÖÁÈç¹é-×ð¹ó-ÏÔºÕIF£º3.8
  • Scientific Reports

    Effect of obesity and NAFLD on leukocyte telomere length and hTERT gene MNS16A VNTR variant

    ½ðʨ¹ó±ö»á-±öÖÁÈç¹é-×ð¹ó-ÏÔºÕÈÕÆÚ£º2024-12-09 ½ðʨ¹ó±ö»á-±öÖÁÈç¹é-×ð¹ó-ÏÔºÕIF£º3.8
¹Ø±Õ

ÔÚÏß×Éѯ

Online consultation

  • ½ðʨ¹ó±ö»á-±öÖÁÈç¹é-×ð¹ó-ÏÔºÕ ÔÚÏß×Éѯ
  • ½ðʨ¹ó±ö»á-±öÖÁÈç¹é-×ð¹ó-ÏÔºÕ ÊÖÒÕÖ§³Ö
½ðʨ¹ó±ö»á-±öÖÁÈç¹é-×ð¹ó-ÏÔºÕ

¹Øע΢ÐŹ«ÖÚºÅ

½ðʨ¹ó±ö»á-±öÖÁÈç¹é-×ð¹ó-ÏÔºÕ

΢ÐÅɨһɨÁ¬Ã¦×Éѯ

΢ÐŵçÄÔ¶Ë×Éѯ
½ðʨ¹ó±ö»á-±öÖÁÈç¹é-×ð¹ó-ÏÔºÕ

΢ÐÅɨһɨÁ¬Ã¦×Éѯ

΢ÐŵçÄÔ¶Ë×Éѯ
¹Ø±Õ
ÍøÕ¾µØͼ
ÓÑÇéÁ´½Ó£ºk1ÌåÓý  AGÆì½¢Ìü  ¿­Ê±ÍøÕ¾Ê×Ò³  »Ê¹Úhg1088  ²©ÌìÓéÀÖAGÆì½¢Ìü×îÐÂÏûÏ¢  ×ðÁú¿­Ê±  ÀÖÌìÌÃfun88  ×¯ÏйÙÍø  ×ðÁú¿­Ê±  PPµç×Ó  ca88¹ÙÍø  ×¯ÏкÍÍøÖ·  SGÑÇÖÞʤÓΠ ÐÓöÎƽ̨  Î¤µÂ¹ÙÍø